Bart is Head of the Department of Ophthalmology, and Staff Member at the Center for Medical Genetics at the Ghent University Hospital and Ghent University. He is Full Professor of Ophthalmology and Ophthalmic Genetics at Ghent University. Since August 2013, Bart also is a part-time (20%) attending physician at the Division of Ophthalmology & Center for Cellular & Molecular Therapeutics at Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Bart Leroy is an ophthalmologist and clinical geneticist specialised in, and passionate about inherited eye disorders. In collaboration with the teams at the University of
Pennsylvania and Children’s Hospital of Philadelphia, Philadelphia, PA, USA, and Ghent University (Hospital), Ghent, Belgium, Bart is involved in phenotyping and genotyping
studies and gene therapy projects for inherited retinal blindness. He was part of the team led by Profs J Bennett, AM Maguire & K High that helped bring Luxturna to market. He is Senior Clinical Investigator of the Research Foundation Flanders (Belgium) since 2010 until 2025. He is (co-)recipient of 30 scientific grants and prizes. Bart is member and board member of several professional organisations, including ISGEDR, SGOF, ERN-EYE and EURETINA.
